Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerHomayoun Zargar, Peter C. Black, Michael S. Cookson et al.|European Urology|2014Cited by 297
Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical CystectomyHomayoun Zargar, Jay B. Shah, Bas W. van Rhijn et al.|The Journal of Urology|2018Cited by 80
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J. Black, Peter C. Black, Homayoun Zargar et al.|Urologic Oncology Seminars and Original Investigations|2019Cited by 44
ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancerLeonardo L. Monteiro, Wassim Kassouf, J. Alfred Witjes et al.|World Journal of Urology|2018Cited by 41